Rankings
▼
Calendar
UTHR FY 2016 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.6B
+9.1% YoY
Gross Profit
$1.5B
95.5% margin
Operating Income
$1.1B
66.4% margin
Net Income
$714M
44.6% margin
EPS (Diluted)
$15.25
Cash Flow
Operating Cash Flow
$644M
Free Cash Flow
$600M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$2.3B
Total Liabilities
$463M
Stockholders' Equity
$1.9B
Cash & Equivalents
$1.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.6B
$1.5B
+9.1%
Gross Profit
$1.5B
$1.4B
+9.3%
Operating Income
$1.1B
$699M
+51.9%
Net Income
$714M
$652M
+9.5%
← FY 2015
All Quarters
Q1 2016 →